No association with breast cancer was found for low levels of the coagulation inhibitors protein C, protein S or free TFPI, but for antithrombin activity below the 10th percentile, the association with breast cancer was ~6-fold higher compared to activity above the 10th percentile. This evidence concerns the gene PROS1 and breast carcinoma.